A confirmation of chronic graft-versus-host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantation
Jed Paul,
Hideki Nakasone,
Bita Sahaf,
Fang Wu,
Kathy Wang,
Vincent Ho,
Juan Wu,
Haesook Kim,
Bruce Blazar,
Jerome Ritz,
Alan Howard,
Corey Cutler,
David Miklos
Affiliations
Jed Paul
Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA
Hideki Nakasone
Division of Hematology, Saitama Medical Center, Jichi Medicial University, Saitama, Japan
Bita Sahaf
Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA
Fang Wu
Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA
Kathy Wang
Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA
Vincent Ho
Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA
Juan Wu
The Emmes Corporation, Rockville, MD, USA
Haesook Kim
Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA
Bruce Blazar
Division of Pediatrics BMT, Minneapolis, MN, USA
Jerome Ritz
Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA
Alan Howard
Center for International Blood and Marrow Transplant Research, Minneapolis Campus, Minneapolis, MN, USA
Corey Cutler
Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA
David Miklos
Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA
